Klinefelter syndrome

Department of Paediatrics and Adolescent Medicine, QMH/HKU, Hong Kong Children's Hospital

Department of Obstetrics and Gynaecology, QMH/HKU

Clinical Genetic Service, Department of Health


What is Klinefelter syndrome?

Klinefelter syndrome is a common genetic condition occurring in males. It affects around 1 in every 500-1000 boys.

Klinefelter syndrome is caused by an additional X chromosome.

Usually, a person has 46 chromosomes in each cell, divided into 23 pairs, which includes two sex chromosomes. For boys, they typically have one X chromosome and one Y chromosome (or known as 46,XY). However, boys with Klinefelter syndrome have an additional X chromosome (47,XXY).

The extra X chromosome may either be carried in every cell in the body or it may only affect some cells (known as mosaic Klinefelter syndrome).

This condition is the result of a chromosomal abnormality and it is usually not inherited. Instead, it occurs as a random event during reproduction.

If you have a son with the condition, the chances of this happening again are very small.

How is Klinefelter syndrome diagnosed?

Klinefelter syndrome may be diagnosed before birth (antenatally), during childhood, at time of puberty, or in adulthood.

Klinefelter syndrome would be suspected based on certain unique clinical characteristics. However, these characteristics can be subtle, and many boys with Klinefelter syndrome do not realize they are affected. Boys born with the condition usually come to medical attention during puberty when they fail to complete puberty normally or when they develop breast enlargement (gynaecomastia). Some present with infertility when they grow up. Occasionally, it is detected incidentally from other investigations, e.g. non-invasive prenatal testing (NIPT) for fetal aneuploidy screening.

To confirm the diagnosis of Klinefelter syndrome, your medical team will order a test that looks at the chromosomes — a karyotype.

I was told that my baby may have Klinefelter syndrome from NIPT; how accurate is it?

A positive result from NIPT for 47, XXY indicates an approximately 70% chance that the fetus could actually have Klinefelter syndrome. To confirm this, you may consider to do an invasive prenatal procedure for karyotype.

What is the implication and what issues can happen?

Klinefelter syndrome can cause a variety of medical and developmental issues. Signs and symptoms of Klinefelter syndrome include:

Can Turner Syndrome be cured or treated?

Klinefelter syndrome is a chromosomal disorder and hence there is no direct cure for the condition. However, a number of treatment approaches can help:

Boys with Klinefelter syndrome need ongoing medical care from a variety of specialists. Nevertheless, the condition is rather well-understood in the medical field and standardized surveillance protocol in taking care of this group of boys is available worldwide. With regular follow-ups and appropriate care, most boys with Klinefelter syndrome can lead happy, healthy, independent lives!

Should I proceed to confirmatory testing? And when?

Options of confirmatory tests and their pros and cons:

  1. Chorionic villus sampling (CVS) could be performed between 11 and 14 weeks of pregnancy. It is the earliest test that could be done. However, there is a 0.1-0.2% procedure-related risk of miscarriage, and a chance of confined placental mosaicism so the result may not represent the fetus.

  2. Amniocentesis could be performed between 16 and 20 weeks of pregnancy. It is more accurate than CVS and can be done earlier than post-natal testing. The procedure-related risk of miscarriage is 0.1-0.2%.

  3. Post-natal blood test could be performed after birth with cord blood or the baby's blood. It is the most accurate and bears no risk of miscarriage, but you will only know about the condition after delivery.

Which confirmatory test should I choose?

Your medical team will discuss with you on your best option based on the best available information. The decision will be affected by the following:

Please contact your doctor for further discussion.


This pamphlet is jointly produced by PAM (QMH / HKU / HCH) , O&G (QMH / HKU) and CGS (DH).